logo
Plus   Neg
Share
Email

Lowe's Q1 Adj. EPS Miss Estimates; Slashes FY19 Adj. EPS Outlook - Quick Facts

Home improvement retailer Lowe's Companies, Inc. (LOW) reported Wednesday a first-quarter net earnings of $1.05 billion or $1.31 per share, higher than $988 million or $1.19 per share in the prior-year quarter.

Excluding a tax benefit and operating costs associated with the Mexico retail operations, adjusted net earnings for the quarter was $1.22 per share.

On average, 27 analysts polled by Thomson Reuters expected the company to report earnings of $1.34 per share for the quarter. Analysts' estimates typically exclude special items.

Sales for the quarter grew 2.2 percent to $17.74 billion from $17.36 billion last year, and comparable sales increased 3.5 percent. Comparable sales for the U.S. home improvement business increased 4.2 percent. Analysts expected sales of $17.70 billion for the quarter.

As of May 3, 2019, Lowe's operated 2,002 home improvement and hardware stores in the United States and Canada representing 208.8 million square feet of retail selling space.

Looking ahead to fiscal 2019, the company slashed its adjusted earnings guidance to a range of $5.45 to $5.65 per share from the prior outlook range of $6.00 to $6.10 per share.

However, the company continues to project total sales for the full year to increase about 2 percent, and comparable sales to increase about 3.0 percent.

The Street is looking for earnings of $6.05 per share on sales growth of 1.6% to $72.44 billion for the year.

"We are still in the early stages of our transformation, and with the changes we are putting in place, we expect to deliver improved gross margin performance over the balance of the year," said Marvin Ellison, Lowe's president and CEO.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration or FDA announced on its website that pharma major Pfizer, Inc. issued recall of two lots of tablets meant to treat acute migraine in adults for concerns over bacteria infection. The pharma company is recalling two lots of Relpax (eletriptan hydrobromide) 40 mg tablets for potential presence of Genus Pseudomonas and Burkholderia bacteria. Cosmetics company Revlon Inc. (REV) is reportedly considering a potential sale of parts or all of its business. According to Bloomberg, Revlon has retained financial advisers from Goldman Sachs Group Inc. to explore strategic alternatives. No deal has been reached yet, but Revlon is exploring all... China's Lenovo Group Ltd. warned it may have to raise prices of its products if the U.S. moves ahead with the decision to impose additional tariffs on Chinese goods, according to a report by Reuters. The warning by Lenovo, the world's largest PC maker, comes amid the escalating trade war between the U.S. and China that has raised concerns about the global economic outlook.
Follow RTT